TMDX - TransMedics Group, Inc.
IEX Last Trade
60.88
0.085 0.140%
Share volume: 33,291
Last Updated: Fri 27 Dec 2024 08:30:17 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$60.80
0.09
0.14%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-04 | 2023-02-27 | 2023-05-04 | 2023-08-04 | 2023-11-08 | 2024-02-27 | 2024-05-02 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 274.873 M | 277.147 M | 287.088 M | 690.358 M | 689.227 M | 706.047 M | 723.831 M | 758.577 M | |
| Current Assets | 250.586 M | 252.294 M | 261.730 M | 662.655 M | 536.724 M | 510.654 M | 488.306 M | 509.265 M | |
| Inventories | 18.575 M | 20.605 M | 23.961 M | 30.545 M | 39.365 M | 44.235 M | 48.541 M | 48.671 M | |
| Other Current Assets | 5.514 M | 2.896 M | 3.774 M | 2.376 M | 9.595 M | 8.031 M | 7.606 M | 16.685 M | |
| Short Term Investments | 5.514 M | 2.896 M | 3.774 M | 2.376 M | 9.595 M | 8.031 M | 7.606 M | 16.685 M | |
| Total Receivables | 22.035 M | 27.611 M | 38.620 M | 47.524 M | 60.654 M | 63.576 M | 81.942 M | 81.158 M | |
| Current Cash | 204.462 M | 201.182 M | 195.375 M | 582.210 M | 427.110 M | 394.812 M | 350.217 M | 362.751 M | |
| Total Non-current Assets | 24.287 M | 24.853 M | 25.358 M | 27.703 M | 152.503 M | 195.393 M | 235.525 M | 249.312 M | |
| Property Plant Equipment | 18.472 M | 19.223 M | 19.161 M | 19.965 M | 131.004 M | 173.941 M | 214.421 M | 229.030 M | |
| Other Assets | 5.315 M | 5.130 M | 5.447 M | 6.988 M | 6.921 M | 6.608 M | 6.311 M | 5.980 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 2.405 M | 2.354 M | 2.303 M | 2.253 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 11.673 M | 11.990 M | 11.990 M | 11.549 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 274.873 M | 277.147 M | 287.088 M | 690.358 M | 689.227 M | 706.047 M | 723.831 M | 758.577 M | |
| Total liabilities | 87.016 M | 89.772 M | 94.463 M | 545.145 M | 562.767 M | 568.845 M | 564.360 M | 568.683 M | |
| Total current liabilities | 20.689 M | 23.661 M | 28.635 M | 32.017 M | 49.101 M | 54.934 M | 50.223 M | 54.329 M | |
| Accounts Payable | 3.080 M | 3.341 M | 4.329 M | 7.031 M | 12.836 M | 12.717 M | 9.225 M | 13.027 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 1.407 M | 1.444 M | 1.481 M | 1.880 M | 1.985 M | 2.035 M | 2.086 M | 2.139 M | |
| Long term debt | 66.327 M | 66.111 M | 65.828 M | 513.128 M | 513.666 M | 513.911 M | 514.137 M | 514.354 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 187.857 M | 187.375 M | 192.625 M | 145.213 M | 126.460 M | 137.202 M | 159.471 M | 189.894 M | |
| Common stock | 30.230 M | 32.063 M | 32.260 M | 32.545 M | 32.614 M | 32.650 M | 32.760 M | 33.120 M | |
| Retained earnings | -471.957 M | -478.677 M | -481.313 M | -482.314 M | -507.736 M | -503.705 M | -491.508 M | -479.314 M |